Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System-Reference-Cited by-同舟云学术

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System

Published:2017-03-21 Issue:11 Volume:31 Page:2449-2457
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Della Porta M G,Jackson C H,Alessandrino E P,Rossi M,Bacigalupo A,van Lint M T,Bernardi M,Allione B,Bosi A,Guidi S,Santini V,Malcovati L,Ubezio M,Milanesi C,Todisco E,Voso M T,Musto P,Onida F^ORCID,Iori A P,Cerretti R,Grillo G,Molteni A,Pioltelli P,Borin L,Angelucci E^ORCID,Oldani E,Sica S,Pascutto C,Ferretti V,Santoro A,Bonifazi F,Cazzola M,Rambaldi A,

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/leu201788.pdf

Reference34 articles.

1. Ades L, Itzykson R, Fenaux P . Myelodysplastic syndromes. Lancet 2014; 383: 2239–2252.

2. Cazzola M, Della Porta MG, Malcovati L . The genetic basis of myelodysplasia and its clinical relevance. Blood 2013; 122: 4021–4034.

3. Cazzola M, Della Porta MG, Travaglino E, Malcovati L . Classification and prognostic evaluation of myelodysplastic syndromes. Semin Oncol 2011; 38: 627–631.

4. Malcovati L, Hellstrom-Lindberg E, Bowen D, Adès L, Cermak J et al. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood 2013; 122: 2943–2964.

5. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088.

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current challenges in conditioning regimens for MDS transplantation;Blood Reviews;2024-09

2. Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes;Journal of Clinical Oncology;2024-08-20

3. Revisiting Timing and Decision Modeling for Allogeneic Hematopoietic Stem-Cell Transplantation in Myelodysplastic Syndromes;Journal of Clinical Oncology;2024-08-20

4. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30

5. How I reduce and treat posttransplant relapse of MDS;Blood;2024-04-04